[Ocular hypertension--follow up or treatment?].

Ocular hypertension is an increase in the pressure in the eyes that is above the range considered normal with no detectable changes in vision or damage to the structure of your eyes. The term is used to distinguish people with elevated pressure from those with glaucoma, but not all people with ocular hypertension will develop this disease. However, there is an increased risk of glaucoma among those with ocular hypertension, so regular comprehensive eye examinations are essential to the overall eye health.

[Ocular complications in eruptive diseases of childhood].

Childhood infectious diseases are not usually serious. The symptoms (fever, conjunctivitis, itching) diminish with the administration of antipyretic drugs. Cutaneous lesions leave no scarring.

[Macular involvement in glaucoma].

Purpose: To assess the macular structural changes in primary open angle glaucoma (POAG) patients.

Methods: A prospective clinical study, 6 months, two groups of patients--group A--case control--healthy subjects, and group B--POAG patients, divided in B1--early glaucoma and B2--advanced glaucoma. The groups were homogeneous about age and sex distribution.

[Cataract surgery and postoperative endophthalmitis].

Unlabelled: The purpose of this paper is to evaluate the incidence of endophthalmitis after the phacoemulsification.

Material And Methods: Retrospective clinical study that includes all the patients that have been operated and all cases of endophthalmitis survived after that in the period between 1.06.

[Age related macular degeneration and C-reactive protein].

C-reactive protein (CRP) is a systemic inflammatory marker associated with the cardiovascular risk profile. Some of the cardiovascular risk factors are linked with the development of age related macular degeneration (AMD), but the correlation between CRP and AMD is not yet well documented. Our current study is trying to emphasize the correlation between plasma CRP levels and the risk for AMD.

[Prostaglandin analogues and central corneal thickness].

Unlabelled: Prostaglandin analogs reduce intraocular pressure (IOP) by activation of matrixmetalloproteinase enzymes (MMP) and increasing uveoscleral outflow. MMP's were found in cornea and their activation could change the central corneal thickness (CCT).

Purpose: To compare the effects of different prostaglandin analogues on central corneal thickness (CCT).

[Refractive stability of foldable intraocular lenses].

Purpose: To compare the refractive stability of different kind of foldable intraocular lenses.

Method: There was performed a two years (mean follow-up 7,4 +/- 1,2 months) prospective interventional case series study on 108 with senile cataract, without another ocular pathology which underwent cataract surgery by phacoemulsification and implantation of foldable intraocular lens (the same surgeon). Each patient had their refractive status measured at the 1-month postoperative visit, 3-months and at the 6-months follow-up visit.